Currently we do not recruite new partcipants to the study.Ìý
The Ultradian project is about developing new tools for the diagnosis and management of endocrine disorders.
Current workup is characterized by repetitive single time point measurements of hormones, often supplemented with complicated and time-consuming dynamic tests.
Ultradian dynamic testing combines ambulatory sampling of interstitial fluid over 24 hours with novel ultra-sensitive assays, allowing characterization of circadian and ultradian hormone rhythms in both health and disease. We hope that this technology will improve the way that endocrine disorders and diagnosed and treated.
The project partnersÌýare:ÌýUniversityÌýof BergenÌý(±·°¿),ÌýUniversity of Bristol(±«°),Ìý(³§),Ìý(S)Ìý(±«°),ÌýandÌýEvangelismos HospitalÌý(GR).ÌýÌýÌý
This project has received funding from the European Union’s Horizon 2020 research and innovation programmeÌýunder grant agreement No 633515.Ìý
